Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

RNA virus evolution adaptation mutant spectrum mutational waves sequence space viral quasispecies

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 02 2020
Historique:
received: 30 10 2019
accepted: 13 12 2019
pubmed: 20 12 2019
medline: 4 9 2020
entrez: 20 12 2019
Statut: epublish

Résumé

Previous studies documented that long-term hepatitis C virus (HCV) replication in human hepatoma Huh-7.5 cells resulted in viral fitness gain, expansion of the mutant spectrum, and several phenotypic alterations. In the present work, we show that mutational waves (changes in frequency of individual mutations) occurred continuously and became more prominent as the virus gained fitness. They were accompanied by an increasing proportion of heterogeneous genomic sites that affected 1 position in the initial HCV population and 19 and 69 positions at passages 100 and 200, respectively. Analysis of biological clones of HCV showed that these dynamic events affected infectious genomes, since part of the fluctuating mutations became incorporated into viable genomes. While 17 mutations were scored in 3 biological clones isolated from the initial population, the number reached 72 in 3 biological clones from the population at passage 200. Biological clones differed in their responses to antiviral inhibitors, indicating a phenotypic impact of viral dynamics. Thus, HCV adaptation to a specific constant environment (cell culture without external influences) broadens the mutant repertoire and does not focus the population toward a limited number of dominant genomes. A retrospective examination of mutant spectra of foot-and-mouth disease virus passaged in cell cultures suggests a parallel behavior here described for HCV. We propose that virus diversification in a constant environment has its basis in the availability of multiple alternative mutational pathways for fitness gain. This mechanism of broad diversification should also apply to other replicative systems characterized by high mutation rates and large population sizes.

Identifiants

pubmed: 31852791
pii: JVI.01856-19
doi: 10.1128/JVI.01856-19
pmc: PMC7158725
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

FEBS J. 2015 Jun;282(11):2089-96
pubmed: 25731961
PLoS One. 2013 Jun 06;8(6):e65726
pubmed: 23762417
Pathogens. 2019 Jun 18;8(2):
pubmed: 31216651
mSphere. 2015 Nov 25;1(1):
pubmed: 27303683
Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
pubmed: 22688811
Liver Int. 2017 Apr;37(4):514-528
pubmed: 28105744
Front Microbiol. 2018 Dec 03;9:2942
pubmed: 30559733
Nat Med. 2005 Jul;11(7):791-6
pubmed: 15951748
Sci Rep. 2015 Mar 09;5:8865
pubmed: 25746010
PLoS Pathog. 2005 Oct;1(2):e11
pubmed: 16220146
J Virol. 2014 Oct;88(20):12098-111
pubmed: 25122776
J Mol Biol. 2003 Oct 24;333(3):553-63
pubmed: 14556744
PLoS Genet. 2019 Oct 17;15(10):e1008271
pubmed: 31622336
PLoS One. 2009 May 25;4(5):e5683
pubmed: 19479085
J Virol. 2009 Sep;83(18):9079-93
pubmed: 19587042
PLoS Genet. 2011 Mar;7(3):e1001344
pubmed: 21437265
Virology. 2018 Oct;523:100-109
pubmed: 30107298
J Virol. 2004 Nov;78(21):11678-85
pubmed: 15479809
J Mol Biol. 1999 Jan 15;285(2):495-505
pubmed: 9878424
J Virol. 2013 Jul;87(13):7593-607
pubmed: 23637397
BMC Infect Dis. 2018 Sep 3;18(1):446
pubmed: 30176817
J Virol. 2011 Apr;85(8):3746-57
pubmed: 21307185
J Virol. 1993 Oct;67(10):6071-9
pubmed: 7690417
Nature. 2006 Jan 19;439(7074):344-8
pubmed: 16327776
PLoS Pathog. 2019 Feb 15;15(2):e1007605
pubmed: 30768648
Transplantation. 2003 Nov 27;76(10):1487-91
pubmed: 14657691
Gastroenterology. 2018 Apr;154(5):1435-1448
pubmed: 29274866
Proc Natl Acad Sci U S A. 2014 May 6;111(18):6678-83
pubmed: 24757055
Virology. 2015 May;479-480:46-51
pubmed: 25824477
Adv Virol. 2018 Nov 19;2018:4835252
pubmed: 30581467
Virology. 2016 Jun;493:227-37
pubmed: 27060566
J Virol. 2007 Nov;81(22):12496-503
pubmed: 17728237
J Gen Virol. 1996 Feb;77 ( Pt 2 ):273-80
pubmed: 8627231
Virus Res. 2017 Jul 15;239:115-125
pubmed: 28040474
J Vet Res. 2018 Dec 31;62(4):447-455
pubmed: 30729201
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2531-5
pubmed: 1313561
Gastroenterology. 2016 Jul;151(1):70-86
pubmed: 27080301
Antimicrob Agents Chemother. 2016 May 23;60(6):3786-93
pubmed: 27067341
Curr Opin Virol. 2019 Feb;34:90-96
pubmed: 30703578
Bioinformatics. 2014 Apr 15;30(8):1104-1111
pubmed: 24389655
Hepatology. 2008 Dec;48(6):1843-50
pubmed: 19003912
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3705-9
pubmed: 8170973
Curr Opin Virol. 2018 Dec;33:74-80
pubmed: 30099321
Environ Microbiol. 2018 Dec;20(12):4612-4628
pubmed: 30452113
J Virol. 2002 Dec;76(24):13001-14
pubmed: 12438626
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31036684
J Virol. 1994 Dec;68(12):8386-91
pubmed: 7966631
Proc R Soc Lond B Biol Sci. 1972 Sep 19;182(1067):109-43
pubmed: 4404185
Virus Res. 2017 Apr 2;233:105-112
pubmed: 28322918
J Virol. 2018 Mar 14;92(7):
pubmed: 29367245
Science. 2005 Jul 22;309(5734):623-6
pubmed: 15947137
Curr Top Microbiol Immunol. 2006;299:261-84
pubmed: 16568902
Gastroenterology. 2018 Mar;154(4):976-988.e4
pubmed: 29146520
J Hepatol. 2016 Oct;65(1 Suppl):S2-S21
pubmed: 27641985
J Mol Biol. 2006 Jul 14;360(3):558-72
pubmed: 16797586
Antimicrob Agents Chemother. 2019 Sep 30;:
pubmed: 31570400
BMC Evol Biol. 2008 Jul 17;8:207
pubmed: 18637173
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6883-8
pubmed: 11371620
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3081-6
pubmed: 11880647
Evolution. 2012 Feb;66(2):363-74
pubmed: 22276534
Semin Liver Dis. 2011 Nov;31(4):356-74
pubmed: 22189976
Mol Phylogenet Evol. 2016 Jan;94(Pt A):264-70
pubmed: 26358613
BMC Genomics. 2015 Feb 22;16:118
pubmed: 25766117
Virology. 1983 Jul 30;128(2):310-8
pubmed: 6310859
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
pubmed: 15939869
J Gen Virol. 2008 Jan;89(Pt 1):232-244
pubmed: 18089747
Curr Top Microbiol Immunol. 2016;392:303-22
pubmed: 26499340
J Virol. 2017 Apr 28;91(10):
pubmed: 28275194
J Virol. 1994 Mar;68(3):1407-17
pubmed: 8107204
Science. 2000 Apr 14;288(5464):339-44
pubmed: 10764648
PLoS One. 2010 Aug 20;5(8):e12303
pubmed: 20808830
Evolution. 2017 Apr;71(4):872-883
pubmed: 28121018
Nat Biotechnol. 2010 Feb;28(2):167-71
pubmed: 20118917
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Nat Microbiol. 2019 Jul;4(7):1075-1087
pubmed: 31160826
Int J Antimicrob Agents. 2018 Oct 10;:105562
pubmed: 30315919

Auteurs

Isabel Gallego (I)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.

María Eugenia Soria (ME)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Carlos García-Crespo (C)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Qian Chen (Q)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Liver Unit, Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.

Patricia Martínez-Barragán (P)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Soumaya Khalfaoui (S)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Brenda Martínez-González (B)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Irene Sanchez-Martin (I)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Inés Palacios-Blanco (I)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Ana Isabel de Ávila (AI)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Damir García-Cehic (D)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Liver Unit, Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.

Juan Ignacio Esteban (JI)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Liver Unit, Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Universitat Autónoma de Barcelona, Barcelona, Spain.

Jordi Gómez (J)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Parasitología y Biomedicina "López-Neyra" (IPBLN, CSIC), Parque Tecnológico Ciencias de la Salud, Armilla, Granada, Spain.

Carlos Briones (C)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Centro de Astrobiología (CAB, CSIC-INTA), Madrid, Spain.

Josep Gregori (J)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Liver Unit, Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Roche Diagnostics, S.L., Sant Cugat del Vallés, Barcelona, Spain.

Josep Quer (J)

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Liver Unit, Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Universitat Autónoma de Barcelona, Barcelona, Spain.

Celia Perales (C)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain cperales@cbm.csic.es edomingo@cbm.csic.es.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.
Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, Madrid, Spain.

Esteban Domingo (E)

Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain cperales@cbm.csic.es edomingo@cbm.csic.es.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH